DE3485733D1 - Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikoerper und verfahren zu ihrer verwendung. - Google Patents

Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikoerper und verfahren zu ihrer verwendung.

Info

Publication number
DE3485733D1
DE3485733D1 DE8484900799T DE3485733T DE3485733D1 DE 3485733 D1 DE3485733 D1 DE 3485733D1 DE 8484900799 T DE8484900799 T DE 8484900799T DE 3485733 T DE3485733 T DE 3485733T DE 3485733 D1 DE3485733 D1 DE 3485733D1
Authority
DE
Germany
Prior art keywords
karzyno
embryonales
cea
antigen
family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484900799T
Other languages
English (en)
Inventor
Frederick James Primus
Milton David Goldenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23826681&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3485733(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3485733D1 publication Critical patent/DE3485733D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE8484900799T 1983-01-21 1984-01-20 Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikoerper und verfahren zu ihrer verwendung. Expired - Lifetime DE3485733D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45991983A 1983-01-21 1983-01-21
PCT/US1984/000077 WO1984002983A1 (en) 1983-01-21 1984-01-20 Specific cea-family antigens, antibodies specific thereto and their methods of use

Publications (1)

Publication Number Publication Date
DE3485733D1 true DE3485733D1 (de) 1992-06-25

Family

ID=23826681

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484900799T Expired - Lifetime DE3485733D1 (de) 1983-01-21 1984-01-20 Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikoerper und verfahren zu ihrer verwendung.

Country Status (8)

Country Link
EP (1) EP0131627B1 (de)
JP (3) JP2598893B2 (de)
AU (2) AU582731B2 (de)
CA (1) CA1274794A (de)
DE (1) DE3485733D1 (de)
DK (1) DK436184A (de)
IL (1) IL70746A (de)
WO (1) WO1984002983A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416774A1 (de) * 1984-05-07 1985-11-14 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper, verfahren zu ihrer herstellung sowie ihre verwendung
NZ212419A (en) * 1984-06-25 1988-08-30 Mucan Diagnostics Pty Ltd In vitro diagnostic test for detecting cancer cells producing mucin antigens
CA1255586A (en) * 1984-07-24 1989-06-13 Hendrik M. Geysen Method of determining mimotopes
WO1986006487A1 (en) * 1985-04-22 1986-11-06 Commonwealth Serum Laboratories Commission Method for determining mimotopes
NZ215865A (en) * 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
US6013772A (en) * 1986-08-13 2000-01-11 Bayer Corporation Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays
JPS6429400A (en) * 1987-07-24 1989-01-31 Akio Hirohashi Monoclonal antibody
US5206086A (en) * 1987-10-13 1993-04-27 University Of Rochester Particle-stabilized epitopes for standardization and control of immunoassays
GB8800078D0 (en) * 1988-01-05 1988-02-10 Ciba Geigy Ag Novel antibodies
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
US6949629B2 (en) 2002-03-13 2005-09-27 Aspenbio, Inc. Methods for purifying selected CEA family member proteins
SG173156A1 (en) 2009-01-27 2011-08-29 Mitsui Chemicals Inc Propylene homopolymer for condensers
CN109189755A (zh) * 2018-09-17 2019-01-11 北京点网聚科技有限公司 一种媒体数据监控方法、装置及计算机可读存储介质

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
US4361544A (en) * 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody
JPH036125B2 (de) * 1980-03-03 1991-01-29 Miruton Deebitsudo Goorudenbaagu
CH642458A5 (en) * 1980-04-25 1984-04-13 Hoffmann La Roche Immunological method
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
DE3416774A1 (de) * 1984-05-07 1985-11-14 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper, verfahren zu ihrer herstellung sowie ihre verwendung
JP3100272B2 (ja) * 1993-09-13 2000-10-16 株式会社日本製鋼所 パリソンのピンチ方法及び装置

Also Published As

Publication number Publication date
JPS60500427A (ja) 1985-03-28
IL70746A0 (en) 1984-04-30
JPH07188299A (ja) 1995-07-25
DK436184D0 (da) 1984-09-12
IL70746A (en) 1990-06-10
JP3074383B2 (ja) 2000-08-07
AU582731B2 (en) 1989-04-13
JPH11315100A (ja) 1999-11-16
JP2936247B2 (ja) 1999-08-23
AU629213B2 (en) 1992-10-01
WO1984002983A1 (en) 1984-08-02
EP0131627A4 (de) 1987-02-26
AU2493184A (en) 1984-08-15
EP0131627B1 (de) 1992-05-20
DK436184A (da) 1984-09-12
JP2598893B2 (ja) 1997-04-09
EP0131627A1 (de) 1985-01-23
AU3529889A (en) 1989-10-12
CA1274794A (en) 1990-10-02

Similar Documents

Publication Publication Date Title
DE3167698D1 (en) Method for the determination of antigens with the aid of two or more monoclonal antibodies
EP0126450A3 (en) Particle and method for the detection of antigens and/or antibodies using this particle
FI844288A0 (fi) Antigen modifikation av polypeptider.
NO843293L (no) Monoklonale antistoffer, samt fremgangsmaate for fremstilling av slike
DE3263249D1 (en) Method for the determination of carcinoembryonic antigen (cea) and suitable antibody solution for the determination
DE3485733D1 (de) Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikoerper und verfahren zu ihrer verwendung.
DE3485628D1 (de) Kupferartiger katalysator und verfahren zu dessen herstellung.
EP0133329A3 (en) Method and reagent for the determination of alpha-amylase
ATE101876T1 (de) Verfahren zur verringerung der heterogenitaet von monoklonalen antikoerpern.
AU546757B2 (en) Urea linked immunogens, antibodies and preparative method
ES531436A0 (es) Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos
PT72832A (de) Substituierte alpha-aminocarbonyl-1-benzyl-3,4-dihidroisochinoline verfahren zu deren herstellung und deren verwendung
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
FI862978A0 (fi) Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö.
EP0218587A4 (de) Monoklonale antikörper und immunisierung damit.
NO165945C (no) Anvendelse av monoklonalt fukosebindende antistoff (ggf) for fremstilling av et termisk denaturert glykosidisk bindingsrelatert antigen (gra).
ATE76510T1 (de) Spezifische antigene der cea(karzyno-embryonales- antigen)familie, spezifische antikoerper und verfahren zu ihrer verwendung.
DE3579857D1 (de) Elektrostatographischer suspensionsentwickler und verfahren zu seiner herstellung.
DK276185D0 (da) Monoklonale antistoffer,fremgangsmaade til fremstilling af disse samt deres diagnostiske anvendelse
DK494084D0 (da) Hybridoma, monokloniske antistoffer frembragt hermed og diagnosemetode under anvendelse af disse
DK37382A (da) Fremgangsmaade til fremstilling af hybridceller,der producereret antistof,fremgangsmaade til fremstilling af antistoffer samt hybridceller og antistoffer
AU546797B2 (en) Monoclonal antibodies against tumor antigens and method
DE3478346D1 (en) Method for assaying basic fetoprotein and reagent therefor
EP0207979A4 (de) Immunologisches verfahren zum messen unstabiler analyten unter verwendung kreuzreaktiver antikörper.
AU2900184A (en) Membrane antigens generated from pooled cells and monoclonal antibodies

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings